OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 15 citing articles:

High FLT3 expression increases immune‐cell infiltration in the tumor microenvironment and correlates with prolonged disease‐free survival in patients with non‐small cell lung cancer
Łukasz Kuncman, Magdalena Orzechowska, Tomasz Milecki, et al.
Molecular Oncology (2024) Vol. 18, Iss. 5, pp. 1316-1326
Open Access | Times Cited: 4

FLT3-Mutated Leukemic Stem Cells: Mechanisms of Resistance and New Therapeutic Targets
Debora Capelli
Cancers (2024) Vol. 16, Iss. 10, pp. 1819-1819
Open Access | Times Cited: 3

Unveiling the role of MDH1 in breast cancer drug resistance through single-cell sequencing and schottenol intervention
Lü Jian, Feng Ding, Yongjie Sun, et al.
Cellular Signalling (2025), pp. 111608-111608
Closed Access

Selective inhibition of CDK9 in triple negative breast cancer
Ebtihal Mustafa, Geraldine Laven‐Law, Zoya Kikhtyak, et al.
Oncogene (2023) Vol. 43, Iss. 3, pp. 202-215
Open Access | Times Cited: 5

Kinase Plasticity in Response to Vandetanib Enhances Sensitivity to Tamoxifen and Identifies Co-Treatment Strategies in Estrogen Receptor Positive Breast Cancer
Rasha T. Kakati, Austin A. Whitman, Santiago Haase, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance
Chang Zheng, Hanbin Guo, Yongpan Mo, et al.
Recent Patents on Anti-Cancer Drug Discovery (2023) Vol. 19, Iss. 5, pp. 681-694
Closed Access | Times Cited: 3

TFAP2C/FLT3 Axis Reduces Ferroptosis in Breast Cancer Cells by Inhibiting Mitochondrial Autophagy
Jiayue Shen, Yali He, Bingchuan Zhou, et al.
The International Journal of Biochemistry & Cell Biology (2024) Vol. 177, pp. 106691-106691
Closed Access

The carcinogenic capacity of arsenic in normal epithelial breast cells and double-positive breast cancer cells
Alina‐Andreea Zimța, Diana Cenariu, Adrian Bogdan Țigu, et al.
Medicine and Pharmacy Reports (2024) Vol. 97, Iss. 2, pp. 184-195
Open Access

Bioinformatics analysis of GPCRs: A window into breast tumorigenesis and metastasis
Safir Ullah Khan, Karla Daniela Hernández-González, Fátima E. Murillo-González, et al.
Research Square (Research Square) (2023)
Open Access

Page 1

Scroll to top